Jane Street holds 5.6% of GeoVax Labs stock
Jane Street Group, LLC and affiliates reported beneficial ownership of 292,833 shares of GeoVax Labs common stock as of 06/03/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Jane Street Group, LLC and affiliates reported beneficial ownership of 292,833 shares of GeoVax Labs common stock as of 06/03/2026. That holding represents 5.6% of the class and is reported as held with shared voting and shared dispositive power.
The filing names subsidiaries Jane Street Capital, LLC (140,064 shares, 2.7%) and Jane Street Global Trading, LLC (152,769 shares, 2.9%) as the relevant holders. Signatures are dated 06/09/2026.
Insights
Jane Street reports a passive, shared 5.6% stake in GeoVax as of 06/03/2026.
The Schedule 13G lists a total beneficial ownership of 292,833 shares representing 5.6% of outstanding common stock, with shared voting and dispositive power. Two subsidiaries are named with split holdings: 140,064 and 152,769 shares respectively.
Reported classification and shared power indicate aggregated institutional holdings rather than sole control. Subsequent filings or amendments would show any change in position or a reclassification to an active filer.
AI-generated analysis. How Rhea-AI works. Not financial advice.